Track the CLARITY PHARMACEUTICALS LTD share price and the full insider trade history of the company, a listed equity based in Australia. Shares are listed on the AU market, under the oversight of ASX. Market capitalisation: €981.2m. The latest transaction was reported on 12 August 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. The full history is free.
9
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CLARITY PHARMACEUTICALS LTD Strong Buy (bullish), based on 4 analysts. Average price target: A$7.20.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CLARITY PHARMACEUTICALS LTD is a company focused on developing innovative treatments for serious diseases. It is listed on the Australian Securities Exchange (XASX).